Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Embecta Corp. stock logo
EMBC
Embecta
$10.51
-14.9%
$12.25
$10.25
$21.48
$614.24M1.24460,053 shs1.41 million shs
Iradimed Corporation stock logo
IRMD
Iradimed
$52.28
-1.7%
$52.25
$41.69
$63.29
$664.74M0.9142,585 shs20,816 shs
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$18.42
-3.7%
$15.11
$11.70
$20.05
$784.97M0.82375,011 shs288,709 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$8.35
-2.0%
$9.73
$8.34
$22.40
$232.52M2.16213,127 shs104,205 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Embecta Corp. stock logo
EMBC
Embecta
+0.49%+6.56%+13.20%-14.30%-9.79%
Iradimed Corporation stock logo
IRMD
Iradimed
-0.15%+2.50%+4.79%-6.88%+20.63%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-2.99%+1.97%+42.16%+6.22%+36.09%
ZimVie Inc. stock logo
ZIMV
ZimVie
-4.05%-2.29%-4.48%-36.04%-50.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Embecta Corp. stock logo
EMBC
Embecta
4.1472 of 5 stars
3.21.03.30.03.01.73.8
Iradimed Corporation stock logo
IRMD
Iradimed
4.8931 of 5 stars
3.53.02.54.43.23.31.9
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.5909 of 5 stars
2.53.00.03.33.02.50.6
ZimVie Inc. stock logo
ZIMV
ZimVie
2.1911 of 5 stars
3.33.00.00.01.91.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Embecta Corp. stock logo
EMBC
Embecta
2.33
Hold$20.3393.47% Upside
Iradimed Corporation stock logo
IRMD
Iradimed
3.00
Buy$72.0037.72% Upside
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.00
Buy$22.5022.15% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3395.61% Upside

Current Analyst Ratings Breakdown

Latest ZIMV, SIBN, IRMD, and EMBC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$24.00 ➝ $24.00
4/10/2025
Embecta Corp. stock logo
EMBC
Embecta
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$15.00
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
Embecta Corp. stock logo
EMBC
Embecta
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
3/13/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
2/27/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$23.00 ➝ $23.00
(Data available from 5/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Embecta Corp. stock logo
EMBC
Embecta
$1.08B0.57$2.43 per share4.32($13.23) per share-0.79
Iradimed Corporation stock logo
IRMD
Iradimed
$75.15M8.84$1.30 per share40.12$5.66 per share9.24
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$176.60M4.44N/AN/A$4.18 per share4.41
ZimVie Inc. stock logo
ZIMV
ZimVie
$443.55M0.52$3.01 per share2.77$15.43 per share0.54
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Embecta Corp. stock logo
EMBC
Embecta
$78.30M$0.9010.513.420.785.25%-19.22%11.92%8/8/2025 (Estimated)
Iradimed Corporation stock logo
IRMD
Iradimed
$19.23M$1.5534.8526.14N/A26.26%24.12%21.20%8/7/2025 (Estimated)
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$43.34M-$0.64N/AN/AN/A-23.82%-22.51%-16.53%8/4/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$393.28M-$0.71N/AN/A-77.31%2.90%1.17%8/7/2025 (Estimated)

Latest ZIMV, SIBN, IRMD, and EMBC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q2 2025
Embecta Corp. stock logo
EMBC
Embecta
$0.66$0.70+$0.04$0.40$261.77 million$259.00 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
5/5/2025Q1 2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 million
2/26/2025Q4 2024
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.25$0.27+$0.02-$0.43$113.67 million$111.52 million
2/24/2025Q4 2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.16-$0.11+$0.05-$0.11$48.87 million$49.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Embecta Corp. stock logo
EMBC
Embecta
$0.605.71%N/A66.67%N/A
Iradimed Corporation stock logo
IRMD
Iradimed
$0.681.30%N/A43.87%1 Years
SI-BONE, Inc. stock logo
SIBN
SI-BONE
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A

Latest ZIMV, SIBN, IRMD, and EMBC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
Embecta Corp. stock logo
EMBC
Embecta
quarterly$0.154.51%5/28/20255/28/20256/13/2025
5/5/2025
Iradimed Corporation stock logo
IRMD
Iradimed
quarterly$0.171.3%5/20/20255/20/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.24
1.67
Iradimed Corporation stock logo
IRMD
Iradimed
N/A
9.21
7.82
SI-BONE, Inc. stock logo
SIBN
SI-BONE
0.22
8.25
7.22
ZimVie Inc. stock logo
ZIMV
ZimVie
0.57
1.94
1.38

Institutional Ownership

CompanyInstitutional Ownership
Embecta Corp. stock logo
EMBC
Embecta
93.83%
Iradimed Corporation stock logo
IRMD
Iradimed
92.34%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
98.11%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Embecta Corp. stock logo
EMBC
Embecta
0.42%
Iradimed Corporation stock logo
IRMD
Iradimed
36.80%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
4.00%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Embecta Corp. stock logo
EMBC
Embecta
1,90058.44 million57.89 millionOptionable
Iradimed Corporation stock logo
IRMD
Iradimed
11012.72 million7.97 millionOptionable
SI-BONE, Inc. stock logo
SIBN
SI-BONE
35042.62 million40.30 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
2,70027.85 million26.77 millionOptionable

Recent News About These Companies

UBS Group Lowers ZimVie (NASDAQ:ZIMV) Price Target to $10.00
Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system

New MarketBeat Followers Over Time

Media Sentiment Over Time

Embecta stock logo

Embecta NASDAQ:EMBC

$10.51 -1.84 (-14.90%)
Closing price 04:00 PM Eastern
Extended Trading
$10.71 +0.20 (+1.90%)
As of 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Iradimed stock logo

Iradimed NASDAQ:IRMD

$52.28 -0.93 (-1.75%)
Closing price 04:00 PM Eastern
Extended Trading
$52.26 -0.02 (-0.05%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

SI-BONE stock logo

SI-BONE NASDAQ:SIBN

$18.42 -0.70 (-3.66%)
Closing price 04:00 PM Eastern
Extended Trading
$18.42 0.00 (0.00%)
As of 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$8.35 -0.17 (-2.00%)
Closing price 04:00 PM Eastern
Extended Trading
$8.36 +0.01 (+0.06%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.